In contrast, SM-2 treatment down-regulated GDF15 expression in cocultured tumor cells (Fig. S11G), suppressed ROS levels (Fig. S11H), and reduced expression of Nrf2 and SOD2 (Fig. S11I). The gene discussed is GDF15; the disease is neoplasm.